TITLE

Prevention with GnRH Antagonist Treatment

PUB. DATE
March 2006
SOURCE
Fertility Weekly;3/6/2006, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the study titled "Treatment with the GnRH Antagonist Ganirelix Prevents Premature LH Rises and Luteinization in Stimulated Intrauterine Insemination: Results of a Double-Blind, Placebo-Controlled, Multicentre Trial," by C.B. Lambalk and colleagues published in "Human Reproduction." The study suggests that treatment with gonadotropin-releasing hormone antagonist (ganirelix) prevents premature rises in luteinizing hormone levels in women undergoing intrauterine insemination with controlled ovarian stiumation.
ACCESSION #
20033912

 

Related Articles

  • Diferencia de respuesta a los antagonistas de GnRH en ciclos de hiperestimulación ovárica más inseminación intrauterina. Carlos Barros-Delgadillo, Juan; Trejo-Castañeda, Heidi; E-Ormsby, Christopher; Gaviño-Gaviño, Fernando // Ginecologia y Obstetricia de Mexico;jan2010, Vol. 78 Issue 1, p15 

    Objetive: To compare two flexible protocols of GnRHant in OH plus lUI vs a control group without GnRHant. Materials and methods: Randomized controlled trial 90 infertile patients were analyzed in 116 cycles of lUI. Cycles were randomized in 3 groups; group 1: started GnRHant when the leading...

  • Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multicentre randomized trial. P.G. Crosignani; E. Somigliana // Human Reproduction;Feb2007, Vol. 22 Issue 2, p500 

    BACKGROUND: The usefulness of GnRH antagonists in mild controlled ovarian hyperstimulation (COH) and intrauterine insemination (IUI) cycles is debated. METHODS: Two-hundred and ninety-nine couples with unexplained or mild male factor infertility were enrolled in this international multicentre...

  • GnRH antagonist ganirelix prevents premature luteinization in IUI cycles: rationale for its use. Martinez-Salazar, Javier; Cerrillo, M.; Quea, G.; Pacheco, A.; Garcia-Velasco, J. A. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Aug2009, Vol. 19 Issue 2, p156 

    This study evaluated the efficacy of a gonadotrophin-releasing hormone antagonist (GnRHa) to prevent premature luteinization (PL) and examined its impact on intrauterine insemination (IUI) cycle outcome. A total of 662 patients who were undergoing IUI were evaluated. Ovarian stimulation was...

  • Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support. Castillo, J.C.; Dolz, M.; Bienvenido, E.; Abad, L.; Casañ, E.M.; Bonilla-Musoles, F. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Feb2010, Vol. 20 Issue 2, p175 

    The aim of this study in patients at risk of ovarian hyperstimulation syndrome (OHSS) was to determine the efficacy and safety of luteal support using human chorionic gonadotrophin (HCG) after triggering ovulation with gonadotrophin-releasing hormone (GnRH) agonist in IVF/intracytoplasmic sperm...

  • The effect of an individualized GnRH antagonist protocol on folliculogenesis in IVF/ICSI. M.H. Mochtar // Human Reproduction;Aug2004, Vol. 19 Issue 8, p1713 

    BACKGROUND: The aim of this study was to assess the effect of an individualized GnRH antagonist regimen on folliculogenesis. METHODS: In a multicentre, randomized, clinical trial, IVF/ICSI patients were allocated to a standard regimen, in which they received daily 0.25 mg GnRH antagonist...

  • Direct ovarian effects and safety aspects of GnRH agonists and antagonists. Tarlatzis, B. C.; Kolibianakis, E. M. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p8 

    The wide application of gonadotrophin-releasing hormone (GnRH) analogues in assisted reproduction has raised concerns about their potential extra-pituitary actions. Although data from animal studies support the presence of ovarian GnRH receptors and of direct ovarian effects of GnRH analogues,...

  • The place of gonadotrophin-releasing hormone antagonists in reproductive medicine. Howles, Colin M. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Supplement 3, Vol. 4 Issue S3, p64 

    Gonadotrophin-releasing hormone (GnRH) antagonists have recently been introduced into clinical practice. They appear to offer a promising alternative to the long-established GnRH agonist regimens for prevention of a premature LH surge during ovarian stimulation for assisted reproductive...

  • Single dose application of cetrorelix in combination with clomiphene for friendly IVF: results of a feasibility study. Engel, Jorg Bernhard; Olivennes, F; Fanchin, R; Frydman, N; Le Du, A; Blanchet, V; Frydman, R // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jun2003, Vol. 6 Issue 4, p444 

    Investigates the feasibility of using clomiphene citrate in combination with gonadotrophins, in a luteinizing hormone-releasing hormone (LHRH) antagonist protocol. Role of LHRH antagonist in assisted reproductive technique; Materials and methods used in the study; Results.

  • Safety aspects of gonadotrophin-releasing hormone antagonists in ovarian stimulation procedures: ovarian hyperstimulation syndrome and health of children born. Ludwig, M.; Katalinic, A.; Felberbaum, R. E.; Diedrich, K. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p61 

    The safety of ovarian stimulation procedures or the procedure of assisted reproduction in general can be estimated by various parameters. Two of the most important are the health of children born after the procedure and the incidence of ovarian hyperstimulation syndrome (OHSS). The latter is...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics